Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Jim Reome who wrote (654)	1/8/1998 8:41:00 PM
From: Amigo Mike	Read Replies (1) \| Respond to of 1476

Hi Jim, I agree with everything you said. My mention of a reverse split is mainly to get the company listed on the NASDAQ. I have been involved in a few reverses myself ..... one of which was wildly successful. The others sucked bad because those companies were lousy. Antex I believe could easily survive a reverse. I think it would also relieve some pressure that Blair puts on the stock. Don't get me wrong.... I'd love for Antex to trade above $4 on its own merits. It should be trading above $2 now as it is. My current valuation model has been adjusted slightly to account for the expiration of warrants. Antex's current value today is : $4.16 ($2.76 fully diluted). WOW ... can you believe that ???? And where are we ???? $1.15. WHY ???? When Antex reports all the trial results in the next few weeks ... the valuation will rise again as the further along the company is in trials ..... the higher the valuation factors. I guesstimate the valuation will rise well above $5 when Antex starts Phase III on Campy and the Phase II trials for H Pylori and H Influenzae start in a few months. Antex is the best kept secret in the market. Just wish it wasn't such a secret any more. Mike